Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Chi

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Circulation|December 28, 2017
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)Gerald Chi, Megan K Yee, Alpesh N Amin, et al.
American Heart Journal|June 20, 2017
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trialsC Michael Gibson, Samuel Z Goldhaber, Alexander T Cohen, et al.
JACC. Advances|June 7, 2025
Persistent Left Ventricular Dysfunction After Spontaneous Coronary Artery Dissection: A Report of the iSCAD RegistryStanislav Henkin, Malissa J Wood, Sahar Naderi, et al.
Thrombosis Research|January 29, 2022
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trialArzu Kalayci, C Michael Gibson, Adrian F Hernandez, et al.
Journal of Thrombosis and Thrombolysis|September 15, 2017
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudyGerald Chi, James L Januzzi, Serge Korjian, et al.
Frontiers in Cardiovascular Medicine|December 30, 2021
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-AnalysisJane J Lee, Gerald Chi, Clara Fitzgerald, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Journal of Thrombosis and Thrombolysis|December 24, 2022
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX TrialGerald Chi, Francesco Violi, Pasquale Pignatelli, et al.
Intensive Care Medicine|February 20, 2019
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudyGerald Chi, C Michael Gibson, Arzu Kalayci, et al.
Medical Hypotheses|December 3, 2020
COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection?Fahimehalsadat Shojaei, Zahra Habibi, Sogand Goudarzi, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Circulation|December 28, 2017
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)Gerald Chi, Megan K Yee, Alpesh N Amin, et al.
American Heart Journal|June 20, 2017
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trialsC Michael Gibson, Samuel Z Goldhaber, Alexander T Cohen, et al.
JACC. Advances|June 7, 2025
Persistent Left Ventricular Dysfunction After Spontaneous Coronary Artery Dissection: A Report of the iSCAD RegistryStanislav Henkin, Malissa J Wood, Sahar Naderi, et al.
Thrombosis Research|January 29, 2022
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trialArzu Kalayci, C Michael Gibson, Adrian F Hernandez, et al.
Journal of Thrombosis and Thrombolysis|September 15, 2017
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudyGerald Chi, James L Januzzi, Serge Korjian, et al.
Frontiers in Cardiovascular Medicine|December 30, 2021
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-AnalysisJane J Lee, Gerald Chi, Clara Fitzgerald, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX TrialMegan K Yee, C Michael Gibson, Tarek Nafee, et al.
Journal of Thrombosis and Thrombolysis|December 24, 2022
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX TrialGerald Chi, Francesco Violi, Pasquale Pignatelli, et al.
Intensive Care Medicine|February 20, 2019
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudyGerald Chi, C Michael Gibson, Arzu Kalayci, et al.
Medical Hypotheses|December 3, 2020
COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection?Fahimehalsadat Shojaei, Zahra Habibi, Sogand Goudarzi, et al.
Pageof 10